RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

ARCA Biopharma Revenue 2024

ARCA Biopharma Revenue

0 USD

ARCA Biopharma Dividend yield

Ticker

ABIO

ISIN

US00211Y5069

WKN

A2PGY6

In 2024, ARCA Biopharma's sales reached 0 USD, a 0% difference from the 0 USD sales recorded in the previous year.

The ARCA Biopharma Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2023--
2022--
2021--
2020--
2019--
2018--
2017--
2016--
2015--
2014--
2013--
2012--
2011--
2010--
2009--
2008--
2007--
2006--
2005--
2004--

ARCA Biopharma Aktienanalyse

What does ARCA Biopharma do?

ARCA Biopharma Inc. is a biopharmaceutical company specializing in the development of therapies for cardiovascular diseases. The company was founded in 2004 and is headquartered in Westminster, Colorado, USA. ARCA Biopharma develops novel drugs tailored to the needs of patients with cardiovascular diseases. The history of ARCA Biopharma began when the company acquired exclusive rights to a technology for identifying genetic mutations associated with increased susceptibility to cardiovascular diseases. Thanks to this technology, ARCA Biopharma was able to develop more targeted, effective therapies based on the patient's genetic makeup. ARCA Biopharma's business model is based on the development of therapeutic technologies for cardiovascular diseases. The company utilizes its expertise in genomic research to develop customized, innovative drug therapies that are more targeted to the patient's genetic needs. ARCA Biopharma conducts intensive research and development work to develop significantly more effective drugs that are aimed at revolutionizing the market. ARCA Biopharma offers various types of medical therapies tailored to the needs of patients with cardiovascular diseases. The company focuses on RNA drug development and genomic research. RNA drugs are a relatively new type of medical therapy based on the regulation of gene expression. The company has several products in various stages of development tailored to the needs of patients with cardiovascular diseases. One of ARCA Biopharma's most successful products is Gencaro, a novel drug used in the treatment of heart failure. Gencaro is a beta-blocker specifically designed for patients with genetic markers associated with increased susceptibility to cardiovascular diseases. ARCA Biopharma has received multiple awards and numerous accolades for its innovation and research work. The company has partnerships with leading research and development organizations around the world to maximize its research efforts and accelerate the development of new innovative drugs. Overall, ARCA Biopharma aims to improve the lives of patients with cardiovascular diseases by providing tailored therapies that meet the genetic needs of the patient. The company has gained a reputation for its innovative research work and the development of highly effective drugs, and will undoubtedly play a leading role in the future development of therapies for cardiovascular diseases. ARCA Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding ARCA Biopharma's Sales Figures

The sales figures of ARCA Biopharma originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing ARCA Biopharma’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize ARCA Biopharma's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in ARCA Biopharma’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about ARCA Biopharma Stock

How much revenue did ARCA Biopharma generate this year?

ARCA Biopharma has achieved a revenue of 0 USD this year.

How much was the turnover of the company ARCA Biopharma compared to the previous year?

The revenue of ARCA Biopharma has increased by 0% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of ARCA Biopharma?

The revenue of ARCA Biopharma is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of ARCA Biopharma measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of ARCA Biopharma so important for investors?

The revenue of ARCA Biopharma is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does ARCA Biopharma pay?

Over the past 12 months, ARCA Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ARCA Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of ARCA Biopharma?

The current dividend yield of ARCA Biopharma is .

When does ARCA Biopharma pay dividends?

ARCA Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ARCA Biopharma?

ARCA Biopharma paid dividends every year for the past 0 years.

What is the dividend of ARCA Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ARCA Biopharma located?

ARCA Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von ARCA Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ARCA Biopharma from 5/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/4/2024.

When did ARCA Biopharma pay the last dividend?

The last dividend was paid out on 5/4/2024.

What was the dividend of ARCA Biopharma in the year 2023?

In the year 2023, ARCA Biopharma distributed 0 USD as dividends.

In which currency does ARCA Biopharma pay out the dividend?

The dividends of ARCA Biopharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The ARCA Biopharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von ARCA Biopharma

Our stock analysis for ARCA Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ARCA Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.